TP53 and ischemic stroke: Therefore, focusing on the alterations of metabolites during the pathogenesis of ischemic stroke and investigating the potential interactions between the metabolites and the p53-mediated apoptotic pathway could contribute to the exploration of new therapeutic strategies for ischemic stroke.